Philip Morris International is the world’s largest tobacco company by volume, with cigarette sales to roughly 170 countries. Despite such dominance, its goal is to completely replace its cigarette ...
Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...
The smoke-free champion marked an 11% rise in its duty-free business, which offset challenges in Australia and Korea’s ...
Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...
Phillip Morris International has reported strong duty-free revenue growth in the company’s 2024 financial results, with the numbers buoyed by a surge in demand for smoke-free products.
Overall revenue was down 5.2% to $32.24 billion, which reflected primarily a reduction in fiscal 2024 revenue following BAT's 2023 divestitures of business in Russia and Belarus in response to ...
Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...
Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...
One concern was the potential for legitimising tobacco industry participation in health debates. In a statement on the decision to divest the business, PMI's chief executive Jacek Olczak said that ...
Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results